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Abstract
Background: Neuropeptide Y (NPY), agouti related peptide (AgRP), cocaine and amphetamine-
regulated transcript (CART) and melanocortins, the products of the proopiomelanocortin
(POMC), are hypothalamic peptides involved in feeding regulation and energy homeostasis. Recent
evidence has demonstrated their expression in rat and human placenta.
Methods: In the current study, we have investigated the expression of those neuropeptides in the
rat placenta by real-time PCR using a model of maternal food restriction.
Results:  Our results showed that placental-derived neuropeptides were regulated through
pregnancy and following food restriction.
Conclusion: These data could indicate that placental-derived neuropeptides represent a local
regulatory circuit that may fine-tune control of energy balance during pregnancy.
Background
The regulation of body weight is carried out by a complex
inter-organ circuit connecting the periphery and the brain,
where neurons in the hypothalamus and brainstem exert
potent effects on feeding and energy expenditure [1,2].
Short-acting and long-term body-weight regulating sig-
nals mainly originate from: 1) the adipose tissue, such as
leptin, and interleukin 6 (IL-6); 2) the pancreas, like insu-
lin or amylin; 3) the gastrointestinal tract such as ghrelin,
glucagon-like peptide-1 (GLP-1), peptide YY (PYY), chole-
cystokinin (CCK) and neuropeptide W (NPW); 4) the sen-
sory vagus nerve [2]. These neural and humoral signals
interact at the brain level with widely-located target recep-
tors related with the nutritional state, metabolism and
reproduction [2,3].
Hypothalamic neuropeptide expression and regulation
are stimulated by inputs from peripherally-derived hor-
monal and nutrient-related signals essential for the central
control of energy homeostasis in mammals. Neuropep-
tide Y (NPY), melanocortins (POMC-derived products),
agouti related peptide (AgRP), cocaine and amphetamine
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regulated transcript (CART), melanin concentrating hor-
mone (MCH) and orexins, have been characterized in
both rodent models and humans, by having either direct
or indirect effects in the feedback loop of body weight reg-
ulation and reproduction [4,5].
NPY and AgRP are two anabolic neuropeptides that pro-
mote weight gain by reducing energy expenditure and
stimulating food intake. They are coexpressed in arcuate
nucleus (ARC) neurons, which are inhibited by insulin
and leptin [4,6]. In contrast, CART and POMC, also coex-
pressed in the ARC neurons, are stimulated by inputs from
insulin and leptin and these catabolic neuronal pathways
act to reduce feeding and increase energy expenditure
[4,6].
Besides their role in food intake control, hypothalamic
neuropeptides have also been identified in female repro-
ductive tissues, such as the placenta and appear to have an
important role in the physiology of pregnancy [7-14]. It is
interesting to note that the placenta may play an impor-
tant role not only in reproduction but is also an important
site for translating inputs from diverse hormonal signals
that powerfully influence energy balance within the fetus
[15,16]. The aim of this study was to evaluate the
ontogenic mRNA expression pattern of NPY, AgRP,
POMC, and CART throughout pregnancy in the rat pla-
centa. In addition, we have determined the effects of
chronic food restriction on their expression levels.
Methods
Animals
Pregnant female rats of the Sprague Dawley strain aged
between 10–12 weeks (bred in the Animalario General
USC; Santiago de Compostela, Spain), were housed in a
temperature-regulated room with a 12 h light/12 h dark
cycle, with tap water and standard rat chow ad libitum or a
food-restricted diet (see below). At the end of the study
period, animals were sacrificed, hypothalami and placen-
tas were removed from each mother, and snap-frozen in
liquid nitrogen for RNA extraction and real time semi-
quantitative RT-PCR. All experiments and procedures in
this study were carried out according to a protocol
approved by the Ethics Committee of the University of
Santiago de Compostela in accordance with the European
Union normative for the care and use of experimental ani-
mals.
Maternal chronic food-restriction
A maternal chronic food-restriction model was used
throughout pregnancy to study the effect of long-term
undernutrition on placental neuropeptide mRNA expres-
sion as previously described [17]. Briefly, virgin rats were
mated on the day of proestrus and the day on which sper-
matozoa were present in vaginal smear, was designated
gestational day 1. The pregnant rats were divided into two
dietary groups: pregnant rats fed ad libitum and food-
restricted group of pregnant rats fed 30% of ad libitum
intake. Food-restricted animals were fed every day at
18:00 hours. Rats were sacrificed at gestational days 12, 16
and 21. We used 9 hypothalami and placentas per experi-
mental group, extracted from 9 different mothers. All the
samples were analyzed individually and samples were not
pooled.
RNA Isolation and real-time RT-PCR
Placental neuropeptide gene expression was analyzed by
reverse transcription polymerase chain reaction (RT-PCR)
as previously validated [18-20]. Total RNA was isolated
using Trizol according to the manufacturer's protocol
(Invitrogen, CA). First-strand cDNA was synthesized from
2 μg of total RNA by random primer reverse transcription.
A negative control without MMLV reverse transcriptase
was used to ensure specificity of the PCR amplification.
The resulting cDNA was subjected to PCR amplification
using sense and antisense primers specific for rat AgRP,
CART, NPY and POMC mRNAs (Table 1). Primer pairs
were designed overlapping on different exons to prevent
amplification from any contaminated genomic DNA
(data not shown). To verify the identity of amplified
cDNAs, PCR products were electrophoresed on a 1.5%
agarose gel, which yielded DNA fragments of the expected
Table 1: Primers used for real-time RT-PCR
mRNA Primer Sequence (5'-3') Product size (bp) Accession Number
NPY Forward cgctctgcgacactacatca 157 NM_012614
Reverse tttcatttcccatcaccaca
AgRP Forward tgtgggccctttattagacc 156 XM_574228
Reverse ccatatggacccccaatgt
POMC Forward tccatagacgtgtggagctg 174 NM_139326
Reverse gacgtacttccggggatttt
CART Forward gccctggacatctactctgc 201 NM_017110
Reverse cactgcgcactgctctcc
HPRT Forward cagtcccagcgtcgtgatta 137 NM_012583
Reverse agcaagtctttcagtcctgtcReproductive Biology and Endocrinology 2008, 6:14 http://www.rbej.com/content/6/1/14
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length for all mRNAs and were confirmed by sequencing
(data not shown). Rat hypoxanthine guanine phosphori-
bosyl transferase (HPRT) was used as a control house-
keeping gene. PCR was performed by real-time in
LightCycler real-time PCR machine 2 (Roche Diagnostics,
Germany) and the software version 3.5, according to the
method described elsewhere [19-21]. Briefly, the PCR pro-
tocol consisted of initial denaturation at 96°C for 5 min,
followed by 35 cycles of denaturation (96°C for 2 s),
annealing (62°C for 15 s) and elongation (72°C for 15 s).
This was followed by melting curve analysis consisting of
1 cycle at 95°C for 30 s, 60°C for 15 s and a temperature
rise to 85°C at a slope of 0.2°C/s with continuous meas-
urement of fluorescence. The primers specify was also
assured by the melting curve of each gene. All samples
were standardized against HPRT by using the 2ΔΔct
method [19,22].
Statistical analysis
Statistical analyzes were performed using GraphPad Instat
(version 3.05). All group values were expressed as mean ±
SEM. Differences between groups were analyzed by using
one-way analysis of variance (ANOVA) or Student's t-test.
P < 0.05 was considered significant.
Results
NPY mRNA expression is down-regulated by food 
restriction in the rat placenta
Firstly, we studied the hypothalamic mRNA levels of NPY
during pregnancy and after food restriction. Our data
showed that the transcriptional expression of NPY is
increased at the latest pregnancy stage (21 days; P < 0.001)
with food restriction inducing a further increase at both
16 and 21 days of pregnancy (P < 0.001 and P < 0.05,
respectively) (Figure 1A). Next, we evaluated the tran-
scriptional expression of NPY in rat placenta; our results
showed that placental mRNA levels of NPY were signifi-
cantly higher during the initial period of gestation studied
(12 days), and decreased significantly (P < 0.001) with
gestational age (Figure 1B). We also studied the effect of
food restriction on placental mRNA expression of NPY
and these data showed that the expression profile of NPY
was decreased by food restriction only at day 12 (P <
0.01), and remain unchanged between 16 to 21 days,
compared to the ad libitum group (Figure 1B).
AgRP mRNA expression is up-regulated by food restriction 
in the rat placenta
Throughout pregnancy, hypothalamic mRNA expression
levels of AgRP were decreased (P < 0.01) at 16 and 21 days
of gestation compared to 12 days and these levels were
increased by food restriction (P < 0.05 and P < 0.01) at all
days of gestation studied compared to the ad libitum (Fig-
ure 2A). In rat placenta, throughout the same experimen-
tal period, the expression mRNA profile of AgRP was
opposite to NPY (Figure 2B). Placental AgRP expression
remained unchanged between 12 and 16 days of gestation
reaching the highest levels at the end of the gestation
period (P < 0.001)(Figure 2B). Food restriction induced a
significant and progressive increase (P < 0.05) in placenta
AgRP mRNA expression at all studied time points.
POMC mRNA expression shows a biphasic response to 
food restriction during pregnancy in rat placenta
Hypothalamic POMC mRNA expression was increased
during pregnancy (P < 0.05) and decreased by food
restriction (P < 0.01) at 12, 16 and 21 days of gestation
(Figure 3A). Placental POMC mRNA expression showed a
significantly (P < 0.001) increasing trend of expression
from 12 to 21 days of gestation in rats fed ad libitum (Fig-
ure 3B). Placental POMC expression was significantly (P <
0.01) lower in fed ad libitum rats than in food-restricted
group at 12 days. Conversely, significantly (P < 0.01)
NPY expression in hypothalamus and placenta of ad libitum  fed and food-restricted rats Figure 1
NPY expression in hypothalamus and placenta of ad 
libitum fed and food-restricted rats. Relative NPY 
mRNA levels in (A) hypothalamus and (B) placenta from ad 
libitum fed or food-restricted female rats at different preg-
nancy stages (12, 16 and 21 days). Relative mRNA levels 
were normalized to ad libitum fed (control) as 1. **: P < 0.01 
vs. ad libitum 12d; ***: P < 0.001 vs. ad libitum 12d; ###: P < 
0.001 vs. ad libitum 16d; !: P < 0.05 ad libitum 21d vs. food-
restricted 21d.
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lower levels of POMC expression were detected in the
food-restricted group at compared to fed ad libitum exper-
imental group from 16 to 21 days of gestation.
CART mRNA expression is down-regulated by food 
restriction in rat placenta
Hypothalamic CART mRNA expression did not show any
change during the different stages of pregnancy and was
decreased by food restriction (P < 0.01) at 21 days of ges-
tation (Figure 4A). Placental CART mRNA expression did
not change significantly from 12 to 16 days, showing the
highest levels (P < 0.001) at 21 days of gestational age. In
addition, CART mRNA expression remained unchanged
throughout pregnancy from 12 to 16 days of pregnancy in
food-restricted rats. Conversely, at 21 days of gestational
age mRNA levels of CART were significantly lower in
food-restricted rats than in fed ad libitum rats (P < 0.01)
(Figure 4B).
Discussion
Although the expression of feeding neuropeptides in pla-
centa is well established, little is known about the regula-
tion of their expression during pregnancy and by
nutritional status. In this study, we investigated the pla-
cental mRNA expression levels of NPY, AgRP, CART and
POMC throughout pregnancy (from day 12 to day 21) in
fed and food-restricted rats.
Fetal development is critically determined by the availa-
bility and flux of nutrients and oxygen across the placenta
during pregnancy. The placenta tissue is an active endo-
crine organ involved in the control of not only metabo-
POMC expression in hypothalamus and placenta of ad libitum  fed and food-restricted rats Figure 3
POMC expression in hypothalamus and placenta of 
ad libitum fed and food-restricted rats. Relative POMC 
mRNA levels in (A) hypothalamus and (B) placenta from ad 
libitum fed or food-restricted female rats at different preg-
nancy stages (12, 16 and 21 days). Relative mRNA levels 
were normalized to ad libitum fed (control) as 1. *: P < 0.05 
vs. ad libitum 12d; **: P < 0.01 vs. ad libitum 12d; ***: P < 0.001 
vs. ad libitum 12d; ##: P < 0.01 vs. ad libitum 16d; ###: P < 
0.001 vs. ad libitum 16d; !!: P < 0.01 ad libitum 21d vs. food-
restricted 21d.
	
	
	









#
#
 
 







 
 

		
  
3
2
0
&

P
5
1
$



+
3
5
7

P
5
1
$

D
U
E
L
W
U
D
U
\
X
Q
L
W
V



3
2
0
&

P
5
1
$



+
3
5
7

P
5
1
$

D
U
E
L
W
U
D
U
\
X
Q
L
W
V



 
 

		
  
	
"	









#



 
AgRP expression in hypothalamus and placenta of ad libitum  fed and food-restricted rats Figure 2
AgRP expression in hypothalamus and placenta of ad 
libitum fed and food-restricted rats. Relative AgRP 
mRNA levels in (A) hypothalamus and (B) placenta from ad 
libitum fed or food-restricted female rats at different preg-
nancy stages (12, 16 and 21 days). Relative mRNA levels 
were normalized to ad libitum fed (control) as 1. *: P < 0.05 
vs.ad libitum 12d; **: P < 0.01 vs. ad libitum 12d; ***: P < 0.001 
vs. ad libitum 12d; #: P < 0.05 vs. ad libitum 16d; ###: P < 
0.001 vs. ad libitum 16d; !: P < 0.05 ad libitum 21d vs. food-
restricted 21d.
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lism and energy balance, but also of other relevant body
functions including reproduction [23,24]. Previous stud-
ies have demonstrated the placental expression of hor-
mones, such as ghrelin and leptin [25-27], as well as
neuropeptides such as NPY, AgRP, CART and POMC [7-
11] are involved in the regulation of energy homeostasis.
However, despite these data, both the physiogical rele-
vance and the regulation of these molecules in placental
tissues remain unclear.
In the hypothalamus, food restriction induces opposite
and compensatory changes in neuropeptide expression.
Thus, orexigenic neuropeptides such as AgRP and NPY are
up-regulated by decreased food availability whilst anorex-
igenic neuropeptides such as CART and POMC are down-
regulated under the same conditions. Interestingly, AgRP,
CART and POMC follow the same expression pattern in
placental tissues but NPY is down-regulated in food-
restricted rats. The reason for this discrepancy is unclear,
but it could be related to an altered hormonal milieu after
food restriction. In this sense, recent data from our group
demonstrates that pregnancy hormones, such as prolac-
tin, play a major role on hypothalamic NPY expression
[28]. Whether this interaction is present in placental tis-
sues will merit further investigation. In addition, these
data support the fact that contrary to the pattern in the
ARC, AgRP and NPY are probably coexpressed by different
cell populations in placental tissue and may be modu-
lated by different signals.
Whatever the case, the discrepancies in NPY expression
pattern suggest that an anabolic role for placental NPY in
states of increased energy demand is not clear and this
possibility merits further investigation. The data from
AgRP, CART and POMC suggest that their expression may
be under the same, or at least, a similar transcriptional
control to that in the hypothalamus. Whether placental
neuropeptide protein levels correlate with mRNA expres-
sion, as in the hypothalamus, will also merit further inves-
tigation.
Conclusion
In summary, we demonstrate that central signals involved
in energy homeostasis in the hypothalamus are also
expressed and modulated by nutritional status in the rat
placenta. These neuropeptides display a specific
ontogenic expression pattern which change over the entire
gestational range. They are also affected by chronic food
restriction. Altogether, these data suggest that neuropep-
tides could play a role in the homeostatic response to
energy availability in rat placenta.
Competing interests
With respect to the disclosure of any financial interest, we
state that none of the authors of this manuscript have any
financial interest that has influenced the results or inter-
pretation of this manuscript.
Authors' contributions
JEC, SBB, CRG, MFG, LAC, ACG performed the experi-
ments. JEC, SBB, CRG, FC, ML and CD edited and
reviewed the manuscript and figures. JEC, SBB, ML and
CD wrote the manuscript.
Acknowledgements
We are very grateful to Dr. Chris Lelliott (AstraZeneca R&D; Mölndal, 
Sweden) for his comments and criticisms. This work has been supported by 
grants from Xunta de Galicia (ML: GRC2006/66), Fondo Investigationes 
Sanitarias (ML: PI061700), Ministerio de Educacion y Ciencia (CD: 
BFU2005), Mútua Madrileña (CD and ML) and European Union (CD: 
LSHM-CT-2003-503041).
References
1. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL:
Is the energy homeostasis system inherently biased toward
weight gain?  Diabetes 2003, 52:232-238.
CART expression in hypothalamus and placenta of ad libitum  fed and food-restricted rats Figure 4
CART expression in hypothalamus and placenta of ad 
libitum fed and food-restricted rats. Relative CART 
mRNA levels in (A) hypothalamus and (B) placenta from ad 
libitum fed or food-restricted female rats at different preg-
nancy stages (12, 16 and 21 days). Relative mRNA levels 
were normalized to ad libitum fed (control) as 1. ***: P < 
0.001 vs. ad libitum 12d; ###: P < 0.001 vs. ad libitum 16d; !!: P 
< 0.01 ad libitum 21d vs. food-restricted 21d.















#

&
$
5
7

P
5
1
$



+
3
5
7

P
5
1
$

D
U
E
L
W
U
D
U
\
X
Q
L
W
V


&
$
5
7

P
5
1
$



+
3
5
7

P
5
1
$

D
U
E
L
W
U
D
U
\
X
Q
L
W
V



 
 

		
  

 
 


 
 

		
  


	
"	

	
	
	
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2008, 6:14 http://www.rbej.com/content/6/1/14
Page 6 of 6
(page number not for citation purposes)
2. Sandoval D, Cota D, Seeley RJ: The Integrative Role of CNS
Fuel-Sensing Mechanisms in Energy Balance and Glucose
Regulation.  Annu Rev Physiol 2008, 70:513-535.
3. Lopez M, Tovar S, Vazquez MJ, Williams LM, Dieguez C: Peripheral
tissue-brain interactions in the regulation of food intake.  Proc
Nutr Soc 2007, 66:131-155.
4. Hillebrand JJ, de Wied D, Adan RA: Neuropeptides, food intake
and body weight regulation: a hypothalamic focus.  Peptides
2002, 23:2283-2306.
5. Schwartz MW, Woods SC, Porte D Jr., Seeley RJ, Baskin DG: Cen-
tral nervous system control of food intake.  Nature 2000,
404:661-671.
6. Leibowitz SF, Wortley KE: Hypothalamic control of energy bal-
ance: different peptides, different functions.  Peptides 2004,
25:473-504.
7. Beloosesky R, Gayle DA, Amidi F, Ahanya SN, Desai M, Ross MG:
Ontogenic expression of putative feeding peptides in the rat
fetal brain and placenta.  Nutr Neurosci 2006, 9:33-40.
8. Grigorakis SI, Anastasiou E, Dai K, Souvatzoglou A, Alevizaki M:
Three mRNA transcripts of the proopiomelanocortin gene
in human placenta at term.  Eur J Endocrinol 2000, 142:533-536.
9. Chen CL, Chang CC, Krieger DT, Bardin CW: Expression and reg-
ulation of proopiomelanocortin-like gene in the ovary and
placenta: comparison with the testis.  Endocrinology 1986,
118:2382-2389.
10. Dotsch J, Nusken KD, Knerr I, Kirschbaum M, Repp R, Rascher W:
Leptin and neuropeptide Y gene expression in human pla-
centa: ontogeny and evidence for similarities to hypotha-
lamic regulation.  J Clin Endocrinol Metab 1999, 84:2755-2758.
11. Singh G, Davenport AP: Neuropeptide B and W: neurotrans-
mitters in an emerging G-protein-coupled receptor system.
Br J Pharmacol 2006, 148:1033-1041.
12. Robidoux J, Simoneau L, St Pierre S, Masse A, Lafond J: Characteri-
zation of neuropeptide Y-mediated corticotropin-releasing
factor synthesis and release from human placental trophob-
lasts.  Endocrinology 2000, 141:2795-2804.
13. Robidoux J, Simoneau L, St Pierre S, Ech-Chadli H, Lafond J: Human
syncytiotrophoblast NPY receptors are located on BBM and
activate PLC-to-PKC axis.  Am J Physiol 1998, 274:E502-E509.
14. Graf AH, Hutter W, Hacker GW, Steiner H, Anderson V, Staudach
A, Dietze O: Localization and distribution of vasoactive neu-
ropeptides in the human placenta.  Placenta 1996, 17:413-421.
15. Garcia MD, Casanueva FF, Dieguez C, Senaris RM: Gestational pro-
file of leptin messenger ribonucleic acid (mRNA) content in
the placenta and adipose tissue in the rat, and regulation of
the mRNA levels of the leptin receptor subtypes in the
hypothalamus during pregnancy and lactation.  Biol Reprod
2000, 62:698-703.
16. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H,
Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K: Nonadipose
tissue production of leptin: leptin as a novel placenta-derived
hormone in humans.  Nat Med 1997, 3:1029-1033.
17. Gualillo O, Caminos JE, Nogueiras R, Seoane LM, Arvat E, Ghigo E,
Casanueva FF, Dieguez C: Effect of food restriction on ghrelin in
normal-cycling female rats and in pregnancy.  Obes Res 2002,
10:682-687.
18. Nogueiras R, Barreiro ML, Caminos JE, Gaytan F, Suominen JS, Nav-
arro VM, Casanueva FF, Aguilar E, Toppari J, Dieguez C, Tena-Sem-
pere M: Novel expression of resistin in rat testis: functional
role and regulation by nutritional status and hormonal fac-
tors.  J Cell Sci 2004, 117:3247-3257.
19. Caminos JE, Bravo SB, Garcia-Rendueles ME, Ruth GC, Garces MF,
Cepeda LA, Lage R, Suarez MA, Lopez M, Dieguez C: Expression of
neuropeptide W in rat stomach mucosa: Regulation by
nutritional status, glucocorticoids and thyroid hormones.
Regul Pept 2007.
20. Lage R, Dieguez C, Lopez M: Caffeine treatment regulates neu-
ropeptide S system expression in the rat brain.  Neurosci Lett
2006, 410:47-51.
21. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative
PCR.  Genome Res 1996, 6:986-994.
22. Livak KJ, Schmittgen TD: Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) Method.  Methods 2001, 25:402-408.
23. Myatt L: Placental adaptive responses and fetal programming.
J Physiol 2006, 572:25-30.
24. Jansson T, Powell TL: Role of the placenta in fetal program-
ming: underlying mechanisms and potential interventional
approaches.  Clin Sci (Lond) 2007, 113:1-13.
25. Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, Kojima M, Kan-
gawa K, Dieguez C, Casanueva F: Ghrelin, a novel placental-
derived hormone.  Endocrinology 2001, 142:788-794.
26. Xiao Q, Han X, Arany E, Hill D, Challis JR, McDonald TJ: Human
placenta and fetal membranes contain peptide YY1-36 and
peptide YY3-36.  J Endocrinol 1998, 156:485-492.
27. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer
JG: Leptin and leptin receptor mRNA and protein expression
in the murine fetus and placenta.  Proc Natl Acad Sci U S A 1997,
94:11073-11078.
28. Garcia MC, Lopez M, Gualillo O, Seoane LM, Dieguez C, Senaris RM:
Hypothalamic levels of NPY, MCH, and prepro-orexin
mRNA during pregnancy and lactation in the rat: role of pro-
lactin.  FASEB J 2003, 17:1392-1400.